European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Identification of efficacious delivery systems for recombinant and nucleic acid construct vaccines (EFFICACIOUS DELIVERY)

Article Category

Article available in the following languages:

Efficacy assay for pig vaccines

Classical swine fever virus (CSFV) causes severe economic losses in the pig industry as it is highly pathogenic and can be responsible for widespread deaths. In the quest for control of this disease, a new quantitative bioassay has been developed to measure vaccine effectiveness.

Health icon Health

As part of the EU-funded EFFICACIOUS DELIVERY novel vaccines have been investigated and developed to tackle CSFV. A significant and important section of this research was the design of a method to evaluate the vaccines' effectiveness. Real time polymerase chain reaction (RT-PCR) assays were developed from pigs vaccinated and then challenged with the virus. Using TaqMan probes, a technique commonly used with RT-PCR, one assay allowed the simultaneous detection of nine sequences. Targets can be selected from a range of immune response proteins including lymphokines and cytokines. For the development of a normalisation factor, project partners calculated the average expression value of three out of four housekeeping genes. These sequences are required for maintenance of the cell and are consequently transcribed at relatively constant levels across all known conditions. Data from sequence targets of interest could then be calculated relative to this factor. Project partners are seeking further research or development support. For interested parties, CSFV represents an excellent model for the evaluation of protective immunity in swine induced by other viral subunits.

Discover other articles in the same domain of application